AmeriHealth Caritas SVP Joins UN Science Summit Panel to Promote Action on Brain Health Equity
New York, New York--(Newsfile Corp. - September 26, 2025) - Dr. Joy Bland, senior vice president of quality & health equity at AmeriHealth Caritas, joined leading experts in health care and innovation at the Science Summit of the 80th United Nations General Assembly to explore how to turn growing awareness of brain health into meaningful, large-scale progress. Brain health – including mental health, neurological disorders, and cognitive conditions – has become
2025-09-26 6:07 PM EDT | AmeriHealth Caritas
NuGen Medical Devices Announces NHS Drug Tariff Approval for EziAutoJector(R) Product Line in the UK
Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to announce that its exclusive UK distribution partner, EziAutoJector® Ltd, has received confirmation from the NHS Business Services Authority, on behalf of the Department of Health, that EziAutoJector® products have been approved for inclusion in the NHS Drug Tariff.
Healthcare and Hospitals, Pharmaceuticals, Health
2025-09-26 5:30 PM EDT | NuGen Medical Devices Inc.
CardioComm Solutions Inc. Announces Insider Purchase of Third-party Loan
Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - CardioComm Solutions Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced that its Chief Executive Officer, Mr. Etienne Grima, has purchased from one of the Company's lenders a loan with a principal value of $80,000 (the "Loan"). The Loan represents a portion of original loans totaling $600,000, which were first a
Technology, Healthcare and Hospitals, Health
2025-09-26 1:40 PM EDT | CardioComm Solutions, Inc.
Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors
Ontario and Chicago, Illinois--(Newsfile Corp. - September 25, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today held its virtual annual meeting of shareholders. Medexus shareholders elected all nominees listed in Medexus's management information circular dated August 12, 2025 as directors through the next annual meeting. Shareholders also voted in favor of the appointment of PricewaterhouseCoopers LLP as the company's auditors. Detailed voting results for the ele
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-09-25 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
White Bear Lake, Minnesota--(Newsfile Corp. - September 25, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,908,402 shares of its Class A common stock at a purchase price of $1.31 per share of Class A common stock. In addition, in a concurrent private plac
Biotechnology, Healthcare and Hospitals
2025-09-25 8:00 AM EDT | Envoy Medical, Inc.
HEALWELL Provides Corporate Update Reflecting Integration Progress and Global Launch of AmadeusAI - the Company's Next Generation AI Enabled Digital Care Record
HEALWELL achieves an exciting integration milestone and announces the global launch of AmadeusAI, now deeply integrated with DARWEN™ AI, providing healthcare providers with advanced artificial intelligence capabilities to analyze structured and unstructured clinical data, identify at-risk patients, and support timely, informed decisions at the point of care. The platform includes HEALWELL's SMARTSuite of AI tools, including SMARTSearch, SMARTS
Technology, Healthcare and Hospitals
2025-09-25 3:15 AM EDT | HEALWELL AI
Kovo+ Holdings Announces Resignation and Appointment of Chief Executive Officer
Calgary, Alberta--(Newsfile Corp. - September 24, 2025) - Kovo+ Holdings Inc. (TSXV: KOVO) ("Kovo" or the "Company") today announces the resignation of Justin Anderson, Chief Executive Officer, due to health reasons effective immediately. The Board of Directors accepts Mr. Anderson's resignation with deep appreciation for his contributions and thanks him for his service and dedication to Kovo. Michael Steele, a current director of the Corporation, will assume the role of Ch
Technology, Healthcare and Hospitals, Internet Technology
2025-09-24 6:51 PM EDT | Kovo+ Holdings Inc.
How Community Frameworks Is Using NewOrg to Simplify Case Management and Unlock Grant Funding
Washington, D.C.--(Newsfile Corp. - September 24, 2025) - NewOrg Management System, Inc., a leading provider of cloud-based data management solutions for nonprofits and local governments, announced today that Community Frameworks has partnered with NewOrg to centralize resident data, streamline supportive service tracking, and simplify grant reporting across its affordable housing programs. For fifty years, Community Frameworks has been a leader in affordable housing development and com
Computer Software, Healthcare and Hospitals, Housing, Aboriginal / Indigenous
2025-09-24 9:00 AM EDT | NewOrg Management System Inc
Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track
White Bear Lake, Minnesota--(Newsfile Corp. - September 24, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing
Biotechnology, Healthcare and Hospitals
2025-09-24 8:00 AM EDT | Envoy Medical, Inc.
Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus
Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses, announced today the peer-reviewed publication of independent preclinical data demonstrating the superiority of its lead antiviral cand
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-09-24 7:00 AM EDT | Theralase Technologies Inc.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
King of Prussia, Pennsylvania--(Newsfile Corp. - September 23, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update on the company's proprietary INTASYL siRNA technology and progress on the on-going clinical
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-09-23 7:45 AM EDT | Phio Pharmaceuticals Corp.
Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
White Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced it has entered into a definitive agreement for the issuance and sale of an aggregate of 1,908,402 shares of its Class A common stock at a purchase price of $1.31 per share of Class A common stock, in a registered direct offering priced at-the-market under Nasd
Biotechnology, Healthcare and Hospitals
2025-09-22 8:00 AM EDT | Envoy Medical, Inc.
Scryb Announces Upsize of Private Placement Following Strong Investor Demand
Toronto, Ontario--(Newsfile Corp. - September 19, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company") is pleased to announce that due to strong market demand, it intends to upsize its previously announced non-brokered private placement (the "Offering") to $1,500,000, or 15,000,000 units of the Company (each, a "Unit") at a price of $0.10 per Unit. Each Unit will consist of one common share (a "Common Share") and one half of one common share p
Biotechnology, Healthcare and Hospitals, Health
2025-09-19 6:59 PM EDT | Scryb Inc.
Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology
White Bear Lake, Minnesota--(Newsfile Corp. - September 19, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that it has received an Issue Notification from the European Patent Office and has been granted European Patent No. 4338791 which became effective September 17, 2025. The newly issued European patent strengthens Envoy Medical's global patent portfolio followin
Biotechnology, Healthcare and Hospitals
2025-09-19 8:00 AM EDT | Envoy Medical, Inc.
Phio Pharmaceuticals to Present at the Life Sciences Future Conference
King of Prussia, Pennsylvania--(Newsfile Corp. - September 18, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary INTASYL® siRNA gene silencing technology to eliminate cancer. Phio today announced that Phio Pharmaceuticals is a presenting company at the Life Sciences Future Conference to be held September 25 - 26, 2025. Mr. Robert Bitterman, President and CEO of Phio
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-09-18 7:45 AM EDT | Phio Pharmaceuticals Corp.
HEALWELL's Intrahealth Selected by Public Health Sudbury & Districts to Implement Advanced EMR Platform
HEALWELL's subsidiary Intrahealth Systems Limited ("Intrahealth") has been selected by Public Health Sudbury & Districts ("Public Health") to implement Profile, its enterprise-grade electronic medical record ("EMR") platform. The deployment will equip Public Health with advanced digital tools to strengthen efficiency, support infectious disease control, vaccination, family health, oral health, sexual health, and environmental health programs.
Technology, Healthcare and Hospitals
2025-09-18 3:15 AM EDT | HEALWELL AI
Scryb Announces Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - September 17, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb'' or the "Company"), is pleased to announce its intention to complete a non-brokered private placement (the "Offering") of up to 6,000,000 units of the Company (each, a "Unit") at a price of $0.10 per Unit, for gross proceeds of up to $600,000 Each Unit will consist of one common share (a "Common Share") and one half of one common share purchase warrant (each a
Biotechnology, Healthcare and Hospitals, Health
2025-09-17 4:05 PM EDT | Scryb Inc.
IR-MED Investor Update Letter - Sept-2025
Rosh Pina, Israel--(Newsfile Corp. - September 16, 2025) - IR-MED Inc. (OTCQB: IRME) ("IR-MED" or the "Company"), a developer of non-invasive artificial intelligence (AI)-powered spectrographic technology to address critical healthcare challenges, today published an investor update. Dear Valued Investors, As we enter September 2025, in addition to Q2 financial reports and to the 8K recently published, I find
Technology, Biotechnology, Healthcare and Hospitals, Health
2025-09-16 4:05 PM EDT | IR-MED, Inc.
Discovery Senior Living Introduces New Brand, Marking the Next Step in Its Evolution and Signaling Its Stability and Strength to Support Future Industry Growth
Bonita Springs, Florida--(Newsfile Corp. - September 15, 2025) - Discovery Senior Living ("Discovery" or the "Company"), one of the largest and most trusted senior housing operators in the U.S., is pleased to announce the launch of its new corporate brand identity and logo. The rebrand reflects the Company's evolution, one that parallels the senior housing industry itself, which has grown more sophisticated, complex, and demanding as capital providers and owners seek trusted operators
Healthcare and Hospitals, Real Estate, Housing
2025-09-15 8:31 AM EDT | Discovery Senior Living
CareRx Initiates Quarterly Dividend and Receives Regulatory Approval for Renewal of its Normal Course Issuer Bid
Toronto, Ontario--(Newsfile Corp. - September 15, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced its intention to pay a quarterly dividend and that the Toronto Stock Exchange ("TSX") has accepted its notice to make a normal course issuer bid to repurchase outstanding common shares in the capital of the Corporation ("Common Sh
2025-09-15 7:30 AM EDT | CareRx Corporation